Pinned post
Soft tissue sarcomas (#STS) have few recurrent mutations, making ctDNA testing a challenge. In our new paper in @JCO_ASCO, we show that personalized ctDNA analysis achieves high detection rates and can track treatment response in localized STS. 🧵 (1/11)
doi.org/10.1200/JCO-26…
ascopubs.org Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to... PURPOSECirculating tumor DNA (ctDNA) holds promise for prognostication and disease monitoring in solid tumors. However, rare and heterogenous tumors with low mutational burden like soft tissue... doi.org/10.1200/JCO-26…